Traphaco JSCSTC:TRA -0.13%83 FCF Margin % is 0.13% as of Mar. 2026, which is 98% below its 10-year median of 7.42. GuruFocus rates STC:TRA with a GF Score™ of 83/100 and a GF Value™ of ₫92,290.93 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 958 Drug Manufacturers companies, Traphaco JSC ranks better than 69.62% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Traphaco JSC's Free Cash Flow for the
three
months ended in Mar. 2026 was ₫809 Mil. Traphaco JSC's Revenue for the
three
months ended in Mar. 2026 was ₫632,847 Mil. Therefore, Traphaco JSC's FCF Margin % for the quarter that ended in Mar. 2026 was 0.13%.
The historical rank and industry rank for Traphaco JSC's FCF Margin % or its related term are showing as below:
STC:TRA'
s FCF Margin % Range Over the Past 10 Years
Min: -3.44 Med: 7.42 Max: 15.83
Current: 9.49
During the past 13 years, the highest FCF Margin % of Traphaco JSC was 15.83%. The lowest was -3.44%. And the median was 7.42%.
STC:TRA's FCF Margin % is ranked better than 69.62% of 958
companies
in the Drug Manufacturers industry
Industry Median: 2.445
vs STC:TRA: 9.49
Traphaco JSC FCF Margin % Related Terms
Traphaco JSC FCF Margin % Historical Data
* Premium members only.
The historical data trend for Traphaco JSC's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Traphaco JSC's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Traphaco JSC FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Traphaco JSC's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Traphaco JSC's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Traphaco JSC (STC:TRA) has a FCF Margin % of 0.13% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Traphaco JSC and its competitors. This is 98% below median its historical median of 7.42. According to the industry distribution chart, Traphaco JSC ranks #291 out of 958 companies in the Drug Manufacturers industry, placing it in the top 30.4%.
Is Traphaco JSC's FCF Margin % too high?
Traphaco JSC's current FCF Margin % of 0.13% is 98% below median its 10-year median of 7.42. The Drug Manufacturers industry median FCF Margin % is 2.45. Traphaco JSC's value of 0.13% is 94.7% below this industry median. Based on the distribution chart, Traphaco JSC ranks #291 out of 958 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Traphaco JSC has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Traphaco JSC's FCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Traphaco JSC ranks #291 out of 958 companies for FCF Margin %. This puts Traphaco JSC in the upper half of its industry. The industry median FCF Margin % is 2.45. Traphaco JSC's value of 0.13% is 94.7% below this benchmark. While the company's 10-year median is 7.42 vs. the industry median of 2.45, Traphaco JSC has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Traphaco JSC's current FCF Margin % of 0.13% is 94.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Traphaco JSC and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Traphaco JSC's current FCF Margin % is 0.13%, which is 98% below median its own 10-year median of 7.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Traphaco JSC stock overvalued right now?
Based on GuruFocus' analysis, Traphaco JSC (STC:TRA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫92,290.93, compared to a current price of ₫77,900.00 — trading 15.6% below its estimated fair value. The current FCF Margin % is 0.13%, which is 98% below median its 10-year median of 7.42 and 94.7% below the Drug Manufacturers industry median of 2.45. Traphaco JSC's overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Traphaco JSC (STC:TRA), the current FCF Margin % is 0.13% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Traphaco JSC (STC:TRA) Overvalued in 2026?
Based on GuruFocus' analysis, Traphaco JSC stock appears to be undervalued.
The current stock price of ₫77,900.00 is trading 15.6% below its estimated GF Value™ of ₫92,290.93.
GuruFocus considers Traphaco JSC to be Modestly Undervalued.
Key valuation signals for STC:TRA:
FCF Margin %: 0.13% (98% below median its 10-year median of 7.42)
GF Value™: ₫92,290.93 vs. price of ₫77,900.00 (15.6% below fair value)
Industry Position: 94.7% below the Drug Manufacturers median (#291 of 958)
No single metric tells the full story. See the STC:TRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Traphaco JSC is engaged in the production and trading of pharmaceuticals, chemicals, and medical supplies and equipment. The company's products are used for nourishing the body, the Skeletal system, for hair, for eyes, the Nervous system, the Respiratory system, and Other groups.
83GF Score
Get the complete analysis for STC:TRA
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STC:TRA has been successfully added to your 
